Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$270.96
1.310.49%
At close: -
$270.96
0.000.00%
After Hours: 4:14 PM EDT
Comments
Loading...
CME Group Analyst Ratings and Price Targets | NASDAQ:CME | Benzinga
CME Group Inc has a consensus price target of $246.04 based on the ratings of 23 analysts. The high is $305 issued by UBS on April 25, 2025. The low is $187 issued by Rosenblatt on April 25, 2024. The 3 most-recent analyst ratings were released by Oppenheimer, UBS, and Morgan Stanley on June 4, 2025, April 25, 2025, and April 24, 2025, respectively. With an average price target of $303 between Oppenheimer, UBS, and Morgan Stanley, there's an implied 11.82% upside for CME Group Inc from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
Oppenheimer
UBS
Morgan Stanley
Keefe, Bruyette & Woods
JP Morgan
1calculated from analyst ratings
Analyst Ratings for CME Group
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 06/04/2025 | Buy Now | 10.72% | Oppenheimer | Owen Lau70% | $282 → $300 | Maintains | Outperform | Get Alert |
| 04/25/2025 | Buy Now | 12.56% | UBS | Alex Kramm73% | $290 → $305 | Maintains | Buy | Get Alert |
| 04/24/2025 | Buy Now | 12.19% | Morgan Stanley | Mike Cyprys59% | $301 → $304 | Maintains | Overweight | Get Alert |
| 04/24/2025 | Buy Now | 0.75% | Keefe, Bruyette & Woods | Kyle Voigt66% | $265 → $273 | Maintains | Market Perform | Get Alert |
| 04/24/2025 | Buy Now | -22.13% | JP Morgan | Kenneth Worthington58% | $223 → $211 | Maintains | Underweight | Get Alert |
| 04/23/2025 | Buy Now | 4.44% | Barclays | Benjamin Budish81% | $279 → $283 | Maintains | Equal-Weight | Get Alert |
| 04/11/2025 | Buy Now | 2.97% | Oppenheimer | Owen Lau70% | $269 → $279 | Maintains | Outperform | Get Alert |
| 04/08/2025 | Buy Now | 11.09% | Morgan Stanley | Patrick Moley87% | $263 → $301 | Upgrade | Equal-Weight → Overweight | Get Alert |
| 04/08/2025 | Buy Now | 4.44% | Piper Sandler | Patrick Moley87% | $275 → $283 | Maintains | Overweight | Get Alert |
| 04/07/2025 | Buy Now | 2.97% | Barclays | Benjamin Budish81% | $263 → $279 | Maintains | Equal-Weight | Get Alert |
| 04/03/2025 | Buy Now | -0.72% | RBC Capital | Ashish Sabadra72% | $269 → $269 | Reiterates | Sector Perform → Sector Perform | Get Alert |
| 04/02/2025 | Buy Now | -19.18% | B of A Securities | Craig Siegenthaler77% | $200 → $219 | Maintains | Underperform | Get Alert |
| 03/10/2025 | Buy Now | 5.92% | Raymond James | Patrick O'Shaughnessy74% | → $287 | Upgrade | Market Perform → Outperform | Get Alert |
| 02/19/2025 | Buy Now | -2.94% | Morgan Stanley | Mike Cyprys59% | $256 → $263 | Maintains | Equal-Weight | Get Alert |
| 02/14/2025 | Buy Now | -5.15% | Keefe, Bruyette & Woods | Kyle Voigt66% | $256 → $257 | Maintains | Market Perform | Get Alert |
| 02/13/2025 | Buy Now | -0.72% | RBC Capital | Ashish Sabadra72% | $235 → $269 | Maintains | Sector Perform | Get Alert |
| 02/13/2025 | Buy Now | -0.72% | Oppenheimer | Owen Lau70% | $258 → $269 | Maintains | Outperform | Get Alert |
| 02/13/2025 | Buy Now | -21.76% | JP Morgan | Kenneth Worthington58% | $209 → $212 | Maintains | Underweight | Get Alert |
| 02/13/2025 | Buy Now | -2.94% | Barclays | Benjamin Budish81% | $257 → $263 | Maintains | Equal-Weight | Get Alert |
| 01/13/2025 | Buy Now | -5.52% | Keefe, Bruyette & Woods | Kyle Voigt66% | $260 → $256 | Maintains | Market Perform | Get Alert |
| 01/07/2025 | Buy Now | -4.78% | Piper Sandler | Patrick Moley87% | $250 → $258 | Maintains | Overweight | Get Alert |
| 01/06/2025 | Buy Now | -13.27% | RBC Capital | Ashish Sabadra72% | $235 → $235 | Reiterates | Sector Perform → Sector Perform | Get Alert |
| 01/06/2025 | Buy Now | -7.74% | Citigroup | Christopher Allen77% | $255 → $250 | Downgrade | Buy → Neutral | Get Alert |
| 12/20/2024 | Buy Now | -4.04% | Keefe, Bruyette & Woods | Kyle Voigt66% | $237 → $260 | Maintains | Market Perform | Get Alert |
| 12/09/2024 | Buy Now | -5.15% | Barclays | Benjamin Budish81% | $231 → $257 | Maintains | Equal-Weight | Get Alert |
| 11/11/2024 | Buy Now | -16.59% | Deutsche Bank | Brian Bedell51% | $227 → $226 | Maintains | Hold | Get Alert |
| 10/28/2024 | Buy Now | -7.74% | Piper Sandler | Patrick Moley87% | $240 → $250 | Maintains | Overweight | Get Alert |
| 10/24/2024 | Buy Now | -13.27% | RBC Capital | Ashish Sabadra72% | $235 → $235 | Reiterates | Sector Perform → Sector Perform | Get Alert |
| 10/24/2024 | Buy Now | -4.78% | Oppenheimer | Owen Lau70% | $245 → $258 | Maintains | Outperform | Get Alert |
| 10/24/2024 | Buy Now | -5.89% | Citigroup | Christopher Allen77% | $250 → $255 | Maintains | Buy | Get Alert |
| 10/24/2024 | Buy Now | -14.75% | Barclays | Benjamin Budish81% | $219 → $231 | Maintains | Equal-Weight | Get Alert |
| 10/17/2024 | Buy Now | -14.01% | Morgan Stanley | Mike Cyprys59% | $210 → $233 | Maintains | Equal-Weight | Get Alert |
| 10/14/2024 | Buy Now | -9.58% | Oppenheimer | Owen Lau70% | $228 → $245 | Maintains | Outperform | Get Alert |
| 10/08/2024 | Buy Now | -9.95% | Redburn Atlantic | Simon Clinch62% | → $244 | Downgrade | Buy → Neutral | Get Alert |
| 10/08/2024 | Buy Now | -11.43% | Piper Sandler | Patrick Moley87% | $225 → $240 | Maintains | Overweight | Get Alert |
| 10/07/2024 | Buy Now | -19.18% | Barclays | Benjamin Budish81% | $209 → $219 | Maintains | Equal-Weight | Get Alert |
| 10/03/2024 | Buy Now | -7.74% | Citigroup | Christopher Allen77% | $240 → $250 | Maintains | Buy | Get Alert |
| 10/03/2024 | Buy Now | -26.93% | Goldman Sachs | Alexander Blostein73% | $195 → $198 | Maintains | Sell | Get Alert |
| 10/03/2024 | Buy Now | -13.27% | RBC Capital | Ashish Sabadra72% | $235 → $235 | Reiterates | Sector Perform → Sector Perform | Get Alert |
| 10/03/2024 | Buy Now | -33.57% | B of A Securities | Craig Siegenthaler77% | $177 → $180 | Maintains | Underperform | Get Alert |
| 09/27/2024 | Buy Now | -13.27% | RBC Capital | Ashish Sabadra72% | → $235 | Initiates | → Sector Perform | Get Alert |
| 09/26/2024 | Buy Now | -18.44% | TD Cowen | Bill Katz69% | → $221 | Initiates | → Hold | Get Alert |
| 09/03/2024 | Buy Now | -34.68% | B of A Securities | Craig Siegenthaler77% | $212 → $177 | Downgrade | Neutral → Underperform | Get Alert |
| 08/20/2024 | Buy Now | -16.96% | Piper Sandler | Patrick Moley87% | $225 → $225 | Reiterates | Overweight → Overweight | Get Alert |
| 08/15/2024 | Buy Now | -26.19% | Deutsche Bank | Brian Bedell51% | $193 → $200 | Maintains | Hold | Get Alert |
| 07/25/2024 | Buy Now | -28.77% | Deutsche Bank | Brian Bedell51% | $195 → $193 | Maintains | Hold | Get Alert |
| 07/25/2024 | Buy Now | -29.51% | JP Morgan | Kenneth Worthington58% | $187 → $191 | Maintains | Underweight | Get Alert |
| 07/25/2024 | Buy Now | -21.39% | Keefe, Bruyette & Woods | Kyle Voigt66% | $212 → $213 | Maintains | Market Perform | Get Alert |
| 07/25/2024 | Buy Now | -22.87% | Barclays | Benjamin Budish81% | $208 → $209 | Maintains | Equal-Weight | Get Alert |
| 07/25/2024 | Buy Now | -16.96% | Piper Sandler | Patrick Moley87% | $235 → $225 | Maintains | Overweight | Get Alert |
| 07/10/2024 | Buy Now | -23.24% | Barclays | Benjamin Budish81% | $228 → $208 | Maintains | Equal-Weight | Get Alert |
| 07/09/2024 | Buy Now | -13.27% | Piper Sandler | Richard Repetto75% | $250 → $235 | Maintains | Overweight | Get Alert |
| 07/03/2024 | Buy Now | -16.59% | Keefe, Bruyette & Woods | Kyle Voigt66% | $226 → $226 | Maintains | Market Perform | Get Alert |
| 06/21/2024 | Buy Now | -30.99% | JP Morgan | Kenneth Worthington58% | $206 → $187 | Downgrade | Neutral → Underweight | Get Alert |
| 04/25/2024 | Buy Now | -15.85% | Barclays | Benjamin Budish81% | $226 → $228 | Maintains | Equal-Weight | Get Alert |
| 04/25/2024 | Buy Now | -20.28% | B of A Securities | Craig Siegenthaler77% | $209 → $216 | Maintains | Neutral | Get Alert |
| 04/25/2024 | Buy Now | -23.97% | JP Morgan | Kenneth Worthington58% | $198 → $206 | Maintains | Neutral | Get Alert |
| 04/25/2024 | Buy Now | -16.59% | Keefe, Bruyette & Woods | Kyle Voigt66% | $222 → $226 | Maintains | Market Perform | Get Alert |
| 04/25/2024 | Buy Now | -30.99% | Rosenblatt | Andrew Bond71% | $185 → $187 | Reiterates | Sell → Sell | Get Alert |
| 04/09/2024 | Buy Now | -16.96% | Morgan Stanley | Mike Cyprys59% | $222 → $225 | Maintains | Equal-Weight | Get Alert |
| 04/08/2024 | Buy Now | -16.59% | Barclays | Benjamin Budish81% | $225 → $226 | Maintains | Equal-Weight | Get Alert |
| 04/05/2024 | Buy Now | -22.5% | Deutsche Bank | Brian Bedell51% | $235 → $210 | Downgrade | Buy → Hold | Get Alert |
| 04/03/2024 | Buy Now | -15.49% | Keefe, Bruyette & Woods | Kyle Voigt66% | → $229 | Maintains | Market Perform | Get Alert |
| 03/06/2024 | Buy Now | -9.58% | Argus Research | Kevin Heal64% | $225 → $245 | Maintains | Buy | Get Alert |
| 02/15/2024 | Buy Now | -16.96% | Barclays | Benjamin Budish81% | $222 → $225 | Maintains | Equal-Weight | Get Alert |
| 01/08/2024 | Buy Now | -18.07% | Barclays | Benjamin Budish81% | $244 → $222 | Downgrade | Overweight → Equal-Weight | Get Alert |
| 01/04/2024 | Buy Now | -33.57% | Rosenblatt | Andrew Bond71% | → $180 | Reiterates | Sell → Sell | Get Alert |
| 01/03/2024 | Buy Now | -28.03% | Goldman Sachs | Alexander Blostein73% | → $195 | Downgrade | Neutral → Sell | Get Alert |
| 10/26/2023 | Buy Now | -9.95% | Barclays | Benjamin Budish81% | $247 → $244 | Maintains | Overweight | Get Alert |
| 10/26/2023 | Buy Now | -18.81% | Morgan Stanley | Mike Cyprys59% | $215 → $220 | Maintains | Equal-Weight | Get Alert |
| 10/26/2023 | Buy Now | -33.57% | Rosenblatt | Andrew Bond71% | $173 → $180 | Maintains | Sell | Get Alert |
| 10/12/2023 | Buy Now | -11.43% | Citigroup | Christopher Allen77% | $215 → $240 | Maintains | Buy | Get Alert |
| 10/11/2023 | Buy Now | -27.3% | JP Morgan | Kenneth Billingsley32% | $190 → $197 | Maintains | Neutral | Get Alert |
| 10/11/2023 | Buy Now | -20.65% | Morgan Stanley | Mike Cyprys59% | $211 → $215 | Maintains | Equal-Weight | Get Alert |
| 10/11/2023 | Buy Now | -11.43% | Deutsche Bank | Brian Bedell51% | $224 → $240 | Maintains | Buy | Get Alert |
| 10/10/2023 | Buy Now | -8.84% | Barclays | Benjamin Budish81% | $230 → $247 | Maintains | Overweight | Get Alert |
| 10/04/2023 | Buy Now | -36.15% | Rosenblatt | Andrew Bond71% | → $173 | Reiterates | Sell → Sell | Get Alert |
| 09/06/2023 | Buy Now | -24.71% | B of A Securities | Craig Siegenthaler77% | $167 → $204 | Upgrade | Underperform → Neutral | Get Alert |
| 07/27/2023 | Buy Now | -15.12% | Barclays | Benjamin Budish81% | $215 → $230 | Maintains | Overweight | Get Alert |
| 07/27/2023 | Buy Now | -26.19% | Keefe, Bruyette & Woods | Kyle Voigt66% | $197 → $200 | Maintains | Market Perform | Get Alert |
| 07/27/2023 | Buy Now | -18.07% | Oppenheimer | Owen Lau70% | → $222 | Reiterates | Outperform → Outperform | Get Alert |
| 07/27/2023 | Buy Now | -22.13% | Morgan Stanley | Mike Cyprys59% | $210 → $211 | Maintains | Equal-Weight | Get Alert |
| 07/27/2023 | Buy Now | -20.65% | Citigroup | Christopher Allen77% | $210 → $215 | Maintains | Buy | Get Alert |
| 07/27/2023 | Buy Now | -36.15% | Rosenblatt | Andrew Bond71% | $169 → $173 | Maintains | Sell | Get Alert |
| 07/13/2023 | Buy Now | -22.5% | Morgan Stanley | Mike Cyprys59% | $208 → $210 | Maintains | Equal-Weight | Get Alert |
| 07/06/2023 | Buy Now | -22.5% | Citigroup | Christopher Allen77% | → $210 | Reiterates | Buy → Buy | Get Alert |
| 07/06/2023 | Buy Now | -37.63% | Rosenblatt | Andrew Bond71% | $161 → $169 | Maintains | Sell | Get Alert |
| 06/28/2023 | Buy Now | -20.65% | Barclays | Benjamin Budish81% | → $215 | Initiates | → Overweight | Get Alert |
| 04/19/2023 | Buy Now | -28.4% | JP Morgan | Kenneth Billingsley32% | $196 → $194 | Maintains | Neutral | Get Alert |
| 04/12/2023 | Buy Now | -18.44% | Oppenheimer | Owen Lau70% | $213 → $221 | Maintains | Outperform | Get Alert |
| 04/11/2023 | Buy Now | -23.24% | Morgan Stanley | Mike Cyprys59% | $201 → $208 | Maintains | Equal-Weight | Get Alert |
| 04/05/2023 | Buy Now | -40.58% | Rosenblatt | Andrew Bond71% | → $161 | Reiterates | → Sell | Get Alert |
| 02/13/2023 | Buy Now | -25.82% | Morgan Stanley | Michael Cyprys68% | $196 → $201 | Maintains | Equal-Weight | Get Alert |
| 02/09/2023 | Buy Now | -40.58% | Rosenblatt | Andrew Bond71% | → $161 | Reiterates | → Sell | Get Alert |
| 02/09/2023 | Buy Now | -23.6% | Credit Suisse | Gautam Sawant65% | $198 → $207 | Maintains | Outperform | Get Alert |
| 02/07/2023 | Buy Now | -26.93% | Credit Suisse | Gautam Sawant65% | $192 → $198 | Maintains | Outperform | Get Alert |
| 01/19/2023 | Buy Now | -21.39% | Oppenheimer | Colin Rusch60% | $218 → $213 | Maintains | Outperform | Get Alert |
| 01/11/2023 | Buy Now | -27.66% | Morgan Stanley | Michael Cyprys68% | $208 → $196 | Maintains | Equal-Weight | Get Alert |
| 01/05/2023 | Buy Now | -29.51% | Credit Suisse | Gautam Sawant65% | → $191 | Upgrade | Neutral → Outperform | Get Alert |
| 12/19/2022 | Buy Now | -7.74% | Piper Sandler | Richard Repetto75% | $270 → $250 | Maintains | Overweight | Get Alert |
FAQ
What is the target price for CME Group (CME) stock?
The latest price target for CME Group (NASDAQ:CME) was reported by Oppenheimer on June 4, 2025. The analyst firm set a price target for $300.00 expecting CME to rise to within 12 months (a possible 10.72% upside). 54 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for CME Group (CME)?
The latest analyst rating for CME Group (NASDAQ:CME) was provided by Oppenheimer, and CME Group maintained their outperform rating.
When was the last upgrade for CME Group (CME)?
The last upgrade for CME Group Inc happened on April 8, 2025 when Morgan Stanley raised their price target to $301. Morgan Stanley previously had an equal-weight for CME Group Inc.
When was the last downgrade for CME Group (CME)?
The last downgrade for CME Group Inc happened on January 6, 2025 when Citigroup changed their price target from $255 to $250 for CME Group Inc.
When is the next analyst rating going to be posted or updated for CME Group (CME)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of CME Group, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for CME Group was filed on June 4, 2025 so you should expect the next rating to be made available sometime around June 4, 2026.
Is the Analyst Rating CME Group (CME) correct?
While ratings are subjective and will change, the latest CME Group (CME) rating was a maintained with a price target of $282.00 to $300.00. The current price CME Group (CME) is trading at is $270.96, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.
